Regence BCBS Medical Policy Updates – January 2019

Click here to view the Regence Blue Cross Blue Shield Medical Policy Updates »

January 2019 Medical Policy Updates:

• Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias
• Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
• Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder
• Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis In Patients With Breast Cancer
• Autologous Hematopoietic Cell Transplantation for Malignant Astrocytomas and Gliomas
• Behavioral Table of Contents
• Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
• Carrier Screening for Genetic Diseases
• Cholesterol Management in Adults
• Cochlear Implant
• Cooling Devices Used in the Home Setting
• Corneal Collagen Cross-Linking
• Cosmetic and Reconstructive Surgery
• Coverage of Treatments Provided in a Clinical Trial
• Deep Brain Stimulation
• Dermabrasion/Microdermabrasion
• Dopamine Transporter Single-Photon Emission Computed Tomography (DAT-SPECT)
• Durable Medical Equipment Table of Contents
• Evaluating the Utility of Genetic Panels
• Gastric Electrical Stimulation
• Gene Expression Profiling for Melanoma
• Gene-Based Tests for Screening, Detection, and/or Management of Prostate Cancer
• Genetic and Molecular Diagnostic Testing
• Genetic Testing for Epilepsy
• Genetic Testing for FMR1 Variants (Including Fragile X Syndrome)
• Genetic Testing for Hereditary Breast and/or Ovarian Cancer
• Genetic Testing for Inherited Susceptibility to Colon Cancer
• Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathies
• Guidelines for the Diagnosis and Treatment of Asthma in Children, Adolescents, and Adults
• Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
• Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
• Hematopoietic Cell Transplantation for Autoimmune Diseases
• Hematopoietic Cell Transplantation for Breast Cancer
• Hematopoietic Cell Transplantation for Chronic Lymphocytic  Leukemia and Small Lymphocytic Lymphoma
• Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia
• Hematopoietic Cell Transplantation for CNS Embryonal Tumors and Ependymoma
• Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer
• Hematopoietic Cell Transplantation for Hodgkin Lymphoma
• Hematopoietic Cell Transplantation for Light-Chain (AL) Amyloidosis or Waldenström Macroglobulinemia
• Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
• Hematopoietic Cell Transplantation for Multiple Myeloma and POEMS Syndrome
• Hematopoietic Cell Transplantation for Non-Hodgkin’s Lymphomas
• Hematopoietic Cell Transplantation for Solid Tumors of Childhood
• Hematopoietic Cell Transplantation in the Treatment of Germ-Cell Tumors
• Identification, Evaluation, and Treatment of Overweight and Obesity in Adults
• Implantable Bone Conduction and Bone-Anchored Hearing Aids
• Implantable Peripheral Nerve Stimulation for Chronic Pain of Peripheral Nerve Origin
• In Vitro Chemoresistance and Chemosensitivity Assays
• Intracardiac Ischemia Monitoring
• Intraocular Radiation Therapy for Age-Related Macular Degeneration
• Laboratory and Genetic Testing for use of Thiopurines
• Laboratory Table of Contents
• Management of Chronic Noncancer Pain with Opioids in Adults
• Management of Heart Failure in Adults
• Mastectomy as a Treatment of Gynecomastia
• Medical Policy Development and Review Process
• Microwave Tumor Ablation
• Molecular Analysis for Targeted Therapy of Non-Small Cell Lung Cancer NSCLC)
• Molecular Testing in the Management of Pulmonary Nodules
• Multianalyte Assays with Algorithmic Analysis for the Evaluation and Monitoring of Patients with Chronic Liver Disease
• Myoelectric Prosthetic Components for the Upper Limb
• New and Emerging Medical Technologies and Technologies
• Occipital Nerve Stimulation
• Orthopedic Applications of Stem Cell Therapy
• Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions
• Percutaneous Axial Lumbosacral Interbody Fusion (LIF)
• Preventive Services Guideline for Adults
• Preventive Services Guideline for Children and Adolescents
• Protein Biomarkers for Screening, Detection, and/or Management of Prostate Cancer
• Retinal Prosthesis
• Sacral Nerve Neuromodulation/Stimulation for Pelvic Floor Dysfunction
• Screening and Management of Substance Use Disorders
• Single-nucleotide Variants (SNVs) to Predict Risk of Nonfamilial Breast Cancer
• Spinal Cord Stimulation
• Subtalar Arthroereisis
• Surgeries for Snoring and Obstructive Sleep Apnea Syndrome
• Transurethral Water Vapor Thermal Therapy of the Prostate
• Treatment for Diabetes in Adults
• Urine Drug Testing for Substance Abuse and Chronic Pain
• Vagus Nerve Stimulation
• Varicose Vein Treatment
• Ventricular Assist Devices and Total Artificial Hearts
• Vitamin D Testing

Click here to view the Regence Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.